Glutathione-deficient mice have increased sensitivity to transplacental benzo[a]pyrene-induced premature ovarian failure and ovarian tumorigenesis

Cancer Research

Volumn 73, Issue 2, 2013, Pages 908-917

  Lim, Jinhwan ^a   Lawson, Gregory W ^c   Nakamura, Brooke N ^a   Ortiz, Laura ^a   Hur, Jin A ^a   Kavanagh, Terrance J ^d   Luderer, Ulrike ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CYTOKERATIN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; FEMALE; GCLM GENE; GENE DELETION; GENOTYPE; GESTATIONAL AGE; GLUTATHIONE METABOLISM; NONHUMAN; OOCYTE; OVARY FOLLICLE; OVARY TUMOR; PREMATURE OVARIAN FAILURE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY;

ANIMALS; BENZO(A)PYRENE; CELL TRANSFORMATION, NEOPLASTIC; ENVIRONMENTAL POLLUTANTS; ESTROUS CYCLE; FEMALE; FERTILITY; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HUMANS; MATERNAL-FETAL EXCHANGE; MICE; OVARIAN FOLLICLE; OVARIAN NEOPLASMS; PREGNANCY; PRIMARY OVARIAN INSUFFICIENCY;

EID: 84872527110     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-3636     Document Type: Article

References (50)

1. Chen VW, Ruiz B, Killeen JL, Cote TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer 2003;97: 2631-42.
2. Li Z, Sandau CD, Romanoff LC, Caudill SP, Sjodin A, Needham LL, et al. Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population. Environ Res 2008;107: 320-31.
3. Mattison DR. Difference in sensitivity of rat and mouse primordial oocytes to destruction by polycyclic aromatic hydrocarbons. Chem Biol Interact 1979;28: 133-7.
4. Mattison DR, Thorgeirsson SS. Ovarian aryl hydrocarbon hydroxylase activity and primordial oocyte toxicity of polycyclic aromatic hydrocarbons in mice. Cancer Res 1979;39: 3471-5.
5. Borman SM, Christian PJ, Sipes IG, Hoyer PB. Ovotoxicity in female fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index. Toxicol Appl Pharmacol 2000;167: 191-8.
6. Baird DD, Wilcox AJ. Cigarette smoking associated with delayed conception. JAMA 1985;253: 2979-83.
7. Jensen TK, Henriksen TB, Hjollund NH, Scheike T, Kolstad H, Giwercman A, et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am J Epidemiol 1998;148: 992-7.
8. Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas 2000;35: 3-9.
9. Biancifiori C, Bonser GM, Caschera F. Ovarian and mammary tumours in intact C3Hb virgin mice following a limited dose of four carcinogenic chemicals. Br J Cancer 1961;15: 270-83.
10. Krarup T. 9: 10-Dimethyl-1: 2-benzanthracene induced ovarian tumours in mice. Acta Pathol Microbiol Scand 1967;70: 241-8.
11. Taguchi O, Michael SD, Nishizuka Y. Rapid Induction of ovarian granulosa cell tumors by 7,2-Dimethylbenz(a)anthracene in neonatally estrogenized mice. Cancer Res 1988;48: 425-9.
12. Gates MA, Rosner BA, Hecht JL, Tworoger SS. Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol 2010;171: 45-53.
13. Terry PD, Miller AB, Jones JG, Rohan TE. Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study. Eur J Cancer 2003;39: 1157-64.
14. MacKenzie KM, Angevine DM. Infertility in Mice exposed in utero to benzo(a)pyrene. Biol Reprod 1981;24: 183-91.
15. Goerttler K, Loehrke H, Hesse B, Milz A, Schweizer J. Diaplacental Initiation of NMRI Mice with 7,12-dimethylbenz[a]anthracene during gestation days 6-20 and postnatal treatment of the F1-generation with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate: tumor incidence in organs other than skin. Carcinogenesis 1981;2: 1087-94.
16. Shorey LE, Castro DJ, Baird WM, Siddens LK, Löhr CV, Matzke MM, et al. Transplacental carcinogenesis with Dibenz[def,p]chrysene (DBC): timing of maternal exposures determines target tissue response in offspring. Cancer Lett 2012;317: 49-55.
17. Xue W, Warshawsky D. Metabolic activation of polycyclic aromatic hydrocarbon and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 2005;206: 73-93.
18. Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, Stoilov I. Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 2003;414: 91-100.
19. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. Expression pattern of mouse and human CYP orthologs (Families 1-4) during development and in different adult tissues. Arch Biochem Biophys 2005;436: 50-61.
20. Rich KJ, Boobis AR. Expression and Inducibility of P450 Enzymes during Liver Ontogeny. Microsc Res Tech 1997;39: 424-35.
21. Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJJ, Perstin J, et al. Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol Sci 2009;108: 4-18.
22. Jernström B, Funk M, Frank H, Mannervik B, Seidel A. Glutathione-Stransferase A1-1-catalysed conjugation of bay and fjord region diol epoxides of polycyclic aromatic hydrocarbons with glutathione. Carcinogenesis 1996;17: 1491-8.
23. Romert L, Dock L, Jenssen D, Jernström B. Effects of glutathione transferase activity on benzo[a]pyrene 7,8-dihydrodiol metabolism and mutagenesis studied in a mammalian cell co-cultivation assay. Cancer Res 1989;10: 1701-7.
24. Stover SK, Gushansky GA, Salmen JJ, Gardiner CS. Regulation of g-glutamate cysteine ligase expression by oxidative stress in the mouse preimplantation embryo. Toxicol Appl Pharmacol 2000;168: 153-9.
25. Richardson L, Venkataraman S, Stevenson P, Yang Y, Burton N, Rao J, et al. EMAGE mouse embryo spatial gene expression database: 2010 update. Nucleic Acids Res 2010;38(Database issue):D703-9.
26. Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med 2009;30: 86-98.
27. Dalton TP, Dieter MZ, Yang Y, Shertzer HG, Nebert DW. Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous. Biochem Biophys Res Commun 2000;279: 324-9.
28. Shi Z-Z, Osei-Frimpong J, Kala G, Kala SV, Barrios RJ, Habib GM, et al. Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proc Natl Acad Sci 2000;97: 5101-6.
29. Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP. Initial characterization of the glutamate cysteine ligase modifier subunit Gclm (-/-) knockout mouse: novel model system for severely compromised oxidative stress response. J Biol Chem 2002;277: 49446-52.
30. McConnachie LA, Mohar I, Hudson FN, Ware CB, Ladiges WC, Fernandez C, et al. Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol Sci 2007;99: 628-36.
31. Nakamura BN, Fielder TJ, Hoang YD, Lim J, McConnachie LA, Kavanagh TJ, et al. Lack of maternal glutamate cysteine ligase modifier subunit (Gclm) decreases oocyte glutathione concentrations and disrupts preimplantation development in mice. Endocrinology 2011;152: 2806-15.
32. Giordano G, White CC, McConnachie LA, Fernandez C, Kavanagh TJ, Costa LG. Neurotoxicity of domoic acid in cerebellar granule neurons in a genetic model of glutathione deficiency. Mol Pharmacol 2006;70: 2116-26.
33. Hirshfield AN. Size-frequency analysis of atresia in cycling rats. Biol Reprod 1988;38: 1181-8.
34. Desmeules P, Devine PJ. Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries. Toxicol Sci 2006;90: 500-9.
35. Canning J, Takai Y, Tilly JL. Evidence for genetic modifiers of ovarian follicular endowment and development from studies of five inbred mouse strains. Endocrinology 2002;144: 9-12.
36. Yang W-L, Cai KQ, Smedberg JL, Smith ER, Klein-Szanto A, Hamilton TC, et al. A reduction of cyclooxygenase 2 gene dosage counters the ovarian morphological aging and tumor phenotype in Wv mice. Am J Pathol 2007;170: 1325-36.
37. Le TM, Willis AS, Barr FE, Cunningham GR, Canter JA, Owens SE, et al. An ethnic-specific polymorphism in the catalytic subunit of glutamatecysteine ligase impairs the production of glutathione intermediates in vitro. Mol Genet Metab 2010;101: 55-61.
38. Nakamura S-I, Kugiyama K, Sugiyama S, Miyamoto S, Koide S-I, Fukushima H, et al. Polymorphism in the 50-flanking region of the human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 2002;105: 2968-73.
39. Nichenametla SN, Ellison I, Calcagnotto A, Lazarus P, Muscat JE, Richie JPJ. Functional significance of the CAG trinucleotide-repeat polymorphism in the gene for the catalytic subunit of g-glutamylcysteine ligase. Free Radic Biol Med 2008;45: 645-50.
40. Walsh AC, Feulner JA, Reilly A. Evidence for functionally significant polymorphism of human glutamate cysteine ligase catalytic subunit: association with glutathione levels and drug resistance in the National Cancer Institute tumor cell line panel. Toxicol Sci 2001;61: 218-23.
41. Takizawa K, Yagi H, Jerina DM, Mattison DR. Murine strain differences in ovotoxicity following intraovarian injection with benzo(a)pyrene, (+)-(7R,8S)-oxide, (-)-(7R,8S)-dihydrodiol, or (+)-(7R,8S)-diol- (9S,10R)-epoxide-2. Cancer Res 1984;44: 2571-6.
42. Uno S, Dalton TP, Dragin N, Curran CP, Derkenne S, Miller ML, et al. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1metabolism required for immunedamage independent of total-body burden and clearance rate. Mol Pharmacol 2006;69: 1103-14.
43. Dey A, Westphal H, Nebert DW. Cell-specific induction of mouse cyp1a1 RNA during development. Proc Natl Acad Sci U S A 1989;86: 7446-50.
44. Winn LM, Wells PG. Evidence for embryonic prostaglandin H synthase catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in pheytoin and benzo[a]pyrene teratogenesis. Free Radic Biol Med 1997;22: 607-21.
45. Parman T, Wells PG. Embryonic prostaglandin H synthase-2 (PHS-2) expression and benzo[a]pyrene teratogenicity in PHS-2 knockout mice. FASEB J 2002;16: 1001-9.
46. Nakamura BN, Mohar I, Lawson GW, Hoang YD, Cortes MM, Ortiz L, et al. Increased sensitivity to testicular toxicity of transplacental benzo[ a]pyrene exposure in male glutamate cysteine ligase modifier subunit Gclm-/-) knockout mice. Toxicol Sci 2012;126: 227-41.
47. Verhofstad N, van Oostrom CTM, Zwart E, Mass LM, van Benthem J, van Schooten F-J, et al. Evaluation of benzo(a)pyrene-induced gene mutations in male germ cells. Toxicol Sci 2011;119: 218-23.
48. Buters J, Quintanilla-Martinez L, Schober W, Soballa VJ, Hintermair J, Wolff T, et al. CYP1B1 determines susceptibility to low doses of 7,12- dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis 2003;24: 327-34.
49. Ramesh A, Archibong AE, Niaz MS. Ovarian susceptibility to benzo[ a]pyrene: tissue burden of metabolites and DNA adducts in F-344 rats. J Toxicol Environ Health, Part A 2010;73: 1611-25.
50. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu H-Y, et al. Aromatic hydrocarbon receptor-driven bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001;28: 355-60.